ABOUT AMCG
Advancing Cardiac Diagnosis Through Quantum Technology
AMCG is a medical technology company pioneering a new approach to cardiac diagnosis through Magnetocardiography (MCG) powered by SQUID quantum sensors.
By capturing the heart's extremely weak magnetic signals, our technology provides a non-invasive, contact-free diagnostic approach without radiation or contrast agents. From advanced sensing hardware to signal analysis, AMCG develops integrated technologies designed to make cardiac assessment simpler and more accessible.
PRODUCTS
A New Approach to Cardiac Diagnosis
Our MCG solutions are designed to meet diverse clinical environments—from bed-type systems for advanced cardiac assessment to compact seated systems for more accessible testing.
Powered by highly sensitive SQUID sensors, AMCG technology measures cardiac magnetic signals in just 3–5 minutes without electrodes, radiation, or contrast agents. We continue to expand our solutions through advanced signal processing and AI-based analysis.
TECHNOLOGY
From Quantum Sensing to AI Analysis
AMCG measures the heart's magnetic signals—about one hundred-millionth of the Earth's magnetic field—with superconducting quantum interference devices (SQUID), built on 30 years of core technology transferred from the Korea Research Institute of Standards and Science.
From the world's first 96-channel measurement system and our proprietary second-generation SQUID sensors to helium re-liquefaction and AI-based interpretation, we develop every core technology in-house—from sensor to analysis.
